2026-04-10T15:43:56+08:002026-04-09|Publish|
  1. Veerabrahma P. Seshachalam#, Ita N. Sari#, Kane Toh#, Prativa Majee, Shay L. Chong, Karthik Sekar, Aziz Aiderus, Khaireen Idzham, Ong Y. Qi, Li Y. Chong, Matias Caldez, Raghuvaran Shanmugam, Dorcas H. H. Ying,  Esmond Lee,  Jiaying Toh, Wu Lele, Jia Y. J. Lee, Guorui Zhong,  Sin C. Chew, Gao B. Chen, Lingyan Wu,  Alexander Y.F. Chung, Peng C. Cheow, Juinn H. Kam, Alfred W.C. Kow,  Wei Q. Leow, Nagalakshmi Jegannathan, Kaina Chen,  Chairat Bunchaliew, Vanessa H. de Villa, Peng S. Koh, Glenn Bonney, Brian K.P. Goh, Wai Leong Tam, Lit-Hsin Loo, Joe Yeong, Vinay Tergaonkar*, Pierce K.H. Chow*. Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrence. JHEP Reports. 2026 (Article in Press). http://doi.org/10.1016/j.jhepr.2026.101790.
  1. Shi W, Ong YQ, Majee P, Wong ES, Velazquez AMV, Fidan K, Chow PK, Tam WL, Tan KK, Tan IB, Tergaonkar V. Pirin Transcriptionally Regulates PLA2G4A To Inhibit Ferroptosis in Colorectal Cancer via Lipid Profile Remodeling. Adv Sci (Weinh). 2026 Feb;13(11):e16385. doi: 10.1002/advs.202516385. Epub 2025 Dec 16. PMID: 41400081; PMCID: PMC12931218.
  1. Chen Y, Huynh VT, Lai L, Liu P, Li T, Tan YB, Chew CS, Velazquez AMV, Samsudin F, Marzinek JK, Bond PJ, Wu B, Luo D, Tergaonkar V. FADDDED filaments coordinate complex IIa assembly during TNF-induced apoptosis. Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2425802122. doi: 10.1073/pnas.2425802122. Epub 2025 Aug 21. PMID: 40838879; PMCID: PMC12403089. (IF 9.1)
  1. Morgan D, Zhang B, Fidan K, Pan W, Vaiyapuri TS, Raju A, Hei D, See TY, Sari IN, Chan JW, Majee P, Balachander A, Yu J, Wong AH, Mok MMH, Foo SH, Tang WL, Ang N, Tan I, Peng YF, Jaynes P, Xu S, Ghosh G, Shahabi S, Jeyasekharan AD, Ikawa M, Zhang Y, Howland SW, Lau MC, Wang VY, Lam KP, Tergaonkar V. The transcription complex p52-ETS1 is essential for germinal center formation. Nature Immunology. 2025 Sep;26(9):1553-1566. doi: 10.1038/s41590-025-02236-1. Epub 2025 Jul 25. PMID: 40715659. (IF 27.6)
  1. Akincilar SC, Fidan K, Kumar N, Ng QF, Majee P, Wu L, Han DJY, Chan CHT, Chua JYH, Idzham K, Oji A, Lee WJJ, Oehlers SH, Ikawa M, Tergaonkar V. Evolutionarily conserved role of telomerase reverse transcriptase in programming the microenvironment via regulation of the cGAS-STING pathway. Nature Cell Biololgy. 2025 Aug;27(8):1342-1356. doi: 10.1038/s41556-025-01706-w. Epub 2025 Aug 6. PMID: 40770487. (IF 26.6).
  1. Wu Z, Wang Z, Ng SQ, Lidster JA, Schwerd-Kleine P, Phua ZJC, Peh KLE, Ho YY, Yuan J, Shathishwaran S, Yeo XH, Zhang Y, Chiu YHJ, Lau LYE, Lim TKH, Takano A, Tan EH, Skanderup AJ, Tergaonkar V, Han W, Ho YS, Tan DSW, Tam WL. Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer. Cell Metabolism. 2025 Nov 4;37(11):2233-2249.e9. doi: 10.1016/j.cmet.2025.10.001. Epub 2025 Oct 24. PMID: 41138721.
  2. Nah GSS, Matsuo J, Bahirvani AG, Kimura S, Chin DWL, Ng KP, Koh CP, Mok MMH, Wang CQ, Tergaonkar V, Voon DC, Kohu K, Muroi S, Shi J, Yu S, Hossain MZ, Liau WS, Phuong CTN, Sanda T, Marsman J, Horsfield J, Cheroutre H, Chan YH, Pang B, Chong PY, Soong R, Tenen DG, Maekawa Y, Venkatesh B, Ito Y, Taniuchi I, Osato M. An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human. Genes Cells. 2025 Nov;30(6):e70052. doi: 10.1111/gtc.70052. Genes Cells. 2025 Nov;30(6):e70066. doi: 10.1111/gtc.70066. PMID: 41111247.
  1. Castro NM, Wang JK, Tergaonkar V, Tan NS, Tanner KE, Tay CY. Calcium release from hydroxyapatite particles influences breast cancer cell osteomimicry and osteolytic behaviors in bone metastases. Biofabrication. 2025 Nov 25;18(1). doi: 10.1088/1758-5090/ae1878. PMID: 41151157.
  1. Ying Chen, Vinh Thang Huynh, Esther Sook Miin Wong, Chan Junwei, Lihua Lai, Amhed Missael Vargas Velazquez, Stephanie Ana Conos, Jaclyn M. Einstein, NGUYEN Thi Minh Nguyet, Ita Novita Sari, Tongyang Li, Weiliang Gan, Leilei Chen, Jinmiao Chen, John Silke, Gene W Yeo, Vinay Tergaonkar. FTO and lncRNA FATALR1 coordinate FADD-RIPK1-Caspase 8. Manuscript under revision in Cell Research.
  1. Du Y, Wang W, Goh HC, Vaiyapuri TS, Raju A, Hsiao YC, Wang CC, Agrawal V, Mohideen NF, Mohd Mazian NB, Karatekin F, Wang WK, Lakshmanan M, Gupta K, Chang H, Le Guezennec X, Bard F, Tan DSW, Tergaonkar V, Hung MC, Liu X, Hong W, Boopathy GTK. A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC). Sci Adv. 2026 Jan 23;12(4):eadv3980. doi: 10.1126/sciadv.adv3980. Epub 2026 Jan 21. PMID: 41564171; PMCID: PMC12822653.
  1. Jiang T, Nam DH, Ram Z, Poo WS, Wang J, Boldbaatar D, Mao Y, Ma W, Mao Q, You Y, Jiang C, Yang X, Tergaonkar V, Zhang W, Wang Z, Kang C, Qiu X, Li S, Chen L, Li X, Liu Z, Bai H, Yao Y, Li S, Wu A, Mou Y, Sai K, Li G, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Yu R, Kang D, Liu Y, Li G, Zhang S, Qu Y, Wang Y, Zhang C, Chen B, You G, Wang Y, Wang Y, Bao Z, Fan X, Liu X, Zhao Z, Li Y, Wang Z, Li G, Fang S, Liu Y, Shan X, Liu Y, Chai R, Hu H, Chen J, Yan W, Cai J, Wang Y; Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNOChina), Chinese Brain Cancer Association (CBCA), Chinese Glioma Genome Atlas (CGGA), Asian Glioma Genome Atlas (AGGA) network. Updated Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Letters. 2025 Dec 1:218185. doi: 10.1016/j.canlet.2025.218185. Epub ahead of print. PMID: 41338443
  1. Ying Chen, Vinh Thang Huynh, Lihua Lai, Ping Liu, Yaw Bia Tan, Amhed Missael Vargas Velazquez, Dahai Luo, Vinay Tergaonkar. Structural Basis of RIPK1 Death Domain Filamentation in TNF-Mediated Apoptosis. Manuscript to be submitted in Cell Research.
  1. Ita Novita Sari, Amhed Missael Vargas Velazquez, Esther Sook Miin Wong, Nguyen Thi Minh Nguyet, Ong Yue Qi, Dorcas Hei Hui Ying, Dhakshayini Morgan, Matias Caldez, Chen Jinmiao, Fu Naiyang, Pierce K.H. Chow, Vinay Tergaonkar. Dysregulation of MIF signaling by Kupffer cells underlies the TNFα-mediated embryonic lethality in mice lacking NFκB components. Manuscript to be submitted in Journal of Hepatology.
  1. Darryl JY Han, David M Costa, Geyang Luo, Kathryn Wright, Manitosh Pandey, Denise Wee, Yao Chen, Semih Can Akincilar, Vinay Tergaonkar, Rajkumar Dorajoo, Guillaume Carissimo, Amit Singhal, Philip M Elks, Catarina M Henriques, Miguel G Ferreira, Bo Yan, Serge Mostowy, Stefan H Oehlers. Non-canonical telomerase function is required for resistance to mycobacterial infection. Manuscript submitted to Ageing Cell.
  1. Benjamin Lebeau, Prachi Amuley, Crystal Chia Yin Ling, Jes Hui Min Kwek, Fuying Dao, Thamil Selvan Vaiyapuri, Anandhkumar Raju, Vinay Tergaonkar, Boon Cher Goh, Melissa Jane Fullwood. Epstein-Barr Virus mediated chromatin clustering sensitizes tumors to increased FTO-catalyzed RNA demethylation by Xanthohumol. Manuscript submitted to Cell.
  1. Long Zhao, Kai Chen, Na Yu, Jiao Yin, Vinay Tergaonkar, Gautam Sethi, Zhe Liu. Harnessing the function of farnesoid X receptor 1 in cancer, diabetes mellitus and cardiovascular diseases. Manuscript submitted to Pharmacological Reviews.
  1. Lindsey D. Hughes, Osman Altun, James Nevin, Facundo Pelorosso, Scott D. Pope, Rieke M. Hackbarth, Mamie Wang, Kerem Fidan, Yuval Kluger, Jonathan A. Leighton, Malay K. Basu, Vinay Tergaonkar, Andrew Oberst, Doug Green, Ruslan Medzhitov, Carla V. Rothlin, Sourav Ghosh. Fibroblasts drive the immediate early tissue response to inflammatory cell death. Manuscript submitted to Nature.
  1. Manickasamy MK, Vishwa R, Sajeev A, Garhwal A, Alqahtani MS, Abbas M, Tergaonkar V, Sethi G, Ma Z, Kunnumakkara AB. The dual facets of MiRNA in modulating NF-κB in breast cancer. Cancer Cell Int. 2025 Dec 31;26(1):55. doi: 10.1186/s12935-025-04101-5. PMID: 41476307; PMCID: PMC12866160.
  1. Kumar A, Daimary UD, Hegde M, Abbas M, Alqahtani MS, Almubarak HA, Tergaonkar V, Sethi G, Kunnumakkara AB. Non-Coding RNA-GATA Axis: Mechanisms and Implications in Cancer Progression and Metastases. Cancers (Basel). 2025 Dec 31;18(1):143. doi: 10.3390/cancers18010143. PMID: 41514651; PMCID: PMC12784915.
  1. Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, Gao B, Ashrafizadeh M, Aref AR, Kalbasi A, Cañadas I, Sethi G, Tergaonkar V, Wang L, Lin Y, Kang D, Klionsky DJ. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resistance Updates. 2025 Jan;78:101170. doi: 10.1016/j.drup.2024.101170. Epub 2024 Nov 15. PMID: 39603146.
  1. Zhang Y, Chen K, Tang SC, Cai Y, Nambu A, See YX, Fu C, Raju A, Lebeau B, Ling Z, Chan JJ, Tay Y, Mutwil M, Lakshmanan M, Tucker-Kellogg G, Chng WJ, Tenen DG, Osato M, Tergaonkar V, Fullwood MJ. Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth. Nat Struct Mol Biol. 2025 Jan;32(1):137-149. doi: 10.1038/s41594-024-01391-7. Epub 2024 Sep 20. PMID: 39304765; PMCID: PMC11746141
  2. Wu N, Zheng W, Zhou Y, Tian Y, Tang M, Feng X, Ashrafizadeh M, Wang Y, Niu X, Tambuwala M, Wang L, Tergaonkar V, Sethi G, Klionsky D, Huang L, Gu M. Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential. Ageing Research Reviews. 2024 Jul 20;100:102428. doi: 10.1016/j.arr.2024.102428.
  1. Ma Q, Hao S, Hong W, Tergaonkar V, Sethi G, Tian Y, Duan C. Versatile function of NF-ĸB in inflammation and cancer. Experimental Hematology&Oncology. 2024 Jul 16;13(1):68. doi: 10.1186/s40164-024-00529-z.
  1. Niibori-Nambu A, Wang CQ, Chin DWL, Chooi JY, Hosoi H, Sonoki T, Tham CY, Nah GSS, Cirovic B, Tan DQ, Takizawa H, Sashida G, Goh Y, Tng J, Fam WN, Fullwood MJ, Suda T, Yang H, Tergaonkar V, Taniuchi I, Li S, Chng WJ, Osato M. Integrin-α9 overexpression underlies the niche-independent maintenance of leukemia stem cells in acute myeloid leukemia. Gene. 2024 Nov 30;928:148761. doi: 10.1016/j.gene.2024.148761.
  1. Shanmugam R, Majee P, Shi W, Ozturk MB, Vaiyapuri TS, Idzham K, Raju A, Shin SH, Fidan K, Low JL, Chua JYH, Kong YC, Qi OY, Tan E, Chok AY, Seow-En I, Wee I, Macalinao DC, Chong DQ, Chang HY, Lee F, Leow WQ, Murata-Hori M, Xiaoqian Z, Shumei C, Tan CSH, Dasgupta R, Tan IB, Tergaonkar V. Iron-(Fe3+) dependent reactivation of telomerase drives colorectal cancers. Cancer Discovery. 2024 Jun 14. doi: 10.1158/2159-8290.CD-23-1379. (IF 39.4)
  1. Nair B, Kamath AJ, Tergaonkar V, Sethi G, Nath LR. Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy. Life Sciences. 2024 Aug 15;351:122818. doi: 10.1016/j.lfs.2024.122818. Epub 2024 Jun 10. PMID: 38866220.
  1. Feng J, Chuah YH, Liang Y, Cipta NO, Zeng Y, Warrier T, Elfar GARE, Yoon J, Grinchuk OV, Tay EXY, Lok KZ, Zheng ZQ, Khong ZJ, Chong ZS, Teo J, Sanford EM, Neo CJY, Chiu HY, Leung JY, Wang LC, Lim YT, Zhao T, Sobota RM, Crasta KC, Tergaonkar V, Taneja R, Ng SY, Cheok CF, Ling SC, Loh YH, Ong DST. PHF2 regulates genome topology and DNA replication in neural stem cells via cohesin. Nucleic Acids Research. 2024 Jul 8;52(12):7063-7080. doi: 10.1093/nar/gkae457.
  1. Lee YF, Chen L, Chew V, Chow EK, Deng LW, Hunziker W, Lee ASG, Leong G, Ngeow J, Pervaiz S, Sabapathy K, Skanderup AJ, Sundar R, Tay Y, Virshup DM, Wong SH, Tergaonkar V, Tam WL. Pushing the Frontiers of Cancer Research: Highlights from the Frontiers in Cancer Science Conference 2023. Cancer Research. 2024 Apr 15;84(8):1195-1198. doi: 10.1158/0008-5472.
  1. Lu Q, Kou D, Lou S, Ashrafizadeh M, Aref AR, Canadas I, Tian Y, Niu X, Wang Y, Torabian P, Wang L, Sethi G, Tergaonkar V, Tay F, Yuan Z, Han P. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. Journal of Hematology & Oncology. 2024 Apr 2;17(1):16. doi: 10.1186/s13045-024-01535-8.
  1. Preedy MK, White MRH, Tergaonkar V. Cellular heterogeneity in TNF/TNFR1 signalling: live cell imaging of cell fate decisions in single cells. Cell Death & Disease. 2024 Mar 11;15(3):202. doi: 10.1038/s41419-024-06559-z.
  1. Das D, Leung JY, Balamurugan S, Tergaonkar V, Loh AHP, Chiang CM, Taneja R. BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO Reports. 2024 Feb;25(2):832-852. doi: 10.1038/s44319-023-00033-1.
  1. Masroni MSB, Lee KW, Lee VKM, Ng SB, Law CT, Poon KS, Lee BT, Liu Z, Tan YP, Chng WL, Tucker S, Ngo LS, Yip GWC, Nga ME, Hue SSS, Putti TC, Bay BH, Lin Q, Zhou L, Hartman M, Loh TP, Lakshmanan M, Lee SY, Tergaonkar V, Chua H, Lee AVH, Yeo EYM, Li MH, Chang CF, Kee Z, Tan KM, Tan SY, Koay ES, Archetti M, Leong SM. Dynamic altruistic cooperation within breast tumors. Molecular Cancer. 2023 Dec 14;22(1):206. doi: 10.1186/s12943-023-01896-7. (IF=41.44)
  1. Lee SY, Teng Y, Son M, Ku B, Moon HS, Tergaonkar V, Chow PK, Lee DW, Nam DH. Correction: High-dose drug heat map analysis for drug safety and efficacy in multi-spheroid brain normal cells and GBM patient-derived cells. PLoS One. 2023 Dec 7;18(12):e0295827. doi: 10.1371/journal.pone.0295827.
  1. Aiderus A, Barker N, Tergaonkar V. Serrated colorectal cancer: preclinical models and molecular pathways. Trends in Cancer. 2024 Jan;10(1):76-91. doi: 10.1016/j.trecan.2023.09.011. (IF 18.4)
  1. Conn VM, Gabryelska M, Toubia J, Kirk K, Gantley L, Powell JA, Cildir G, Marri S, Liu R, Stringer BW, Townley S, Webb ST, Lin H, Samaraweera SE, Bailey S, Moore AS, Maybury M, Liu D, Colella AD, Chataway T, Wallington-Gates CT, Walters L, Sibbons J, Selth LA, Tergaonkar V, D’Andrea RJ, Pitson SM, Goodall GJ, Conn SJ. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia. Cancer Cell. 2023 Jul 10;41(7):1309-1326.e10. doi: 10.1016/j.ccell.2023.05.002. (IF 38.59)
  1. Zhang J, Hu Z, Chung HH, Tian Y, Lau KW, Ser Z, Lim YT, Sobota RM, Leong HF, Chen BJ, Yeo CJ, Tan SYX, Kang J, Tan DEK, Sou IF, McClurg UL, Lakshmanan M, Vaiyapuri TS, Raju A, Wong ESM, Tergaonkar V, Rajarethinam R, Pathak E, Tam WL, Tan EY, Tee WW. Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. Nature Communications. 2023 Apr 28;14(1):2439. doi: 10.1038/s41467-023-38132-1. (IF 14.9)
  1. Nassour, J., Aguiar, L., Correia, A., Schmidt, T., Mainz, L., Haggblom, C., Williams, A., Shokhirev, M., Akincilar, S., Tergaonkar, V., Shadel, G., Jan Karlseder, J. (2023). Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis. Nature, 614(7949), 767–773. (IF=69.5)
  1. Yeo SJ, Ying C, Fullwood MJ, Tergaonkar V. Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains. Trends Genet. 2023 Mar;39(3):217-232. doi: 10.1016/j.tig.2022.12.003. (IF=12)
  1. Koh CP, Bahirvani AG, Wang CQ, Yokomizo T, Ng CEL, Du L, Tergaonkar V, Voon DC, Kitamura H, Hosoi H, Sonoki T, Michelle MMH, Tan LJ, Niibori-Nambu A, Zhang Y, Perkins AS, Hossain Z, Tenen DG, Ito Y, Venkatesh B, Osato M. Highly efficient Runx1 enhancer eR1-mediated genetic engineering for fetal, child and adult hematopoietic stem cells. Gene. 2023 Jan 30;851:147049. doi: 10.1016/j.gene.2022.147049. (IF= 3.91)
  1. Akincilar, S., Chua, J., Ng, Q., Chan, Tzer, C., Zahra, E., Chen, K., Low, J., Arumugam, S., Aswad , L., Chua , C., Tan , I., Dasgupta, R., Fullwood, M., Tergaonkar, V. (2022). Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer. Nucleic Acids Research. Accepted as Breakthrough Article, 51,1 (2023): 1-16. (IF=19.33)
  1. Ashrafizadeh, M., Zarrabi, A., Mostafavi, E., Aref, A. R., Sethi, G., Wang, L., & Tergaonkar, V. (2022). Non-coding RNA-based regulation of inflammation. Seminars in immunology, 59, 01606. (IF=11.1)
  1. Zhang, Y., See, Y. X., Tergaonkar, V., & Fullwood, M. J. (2022). Long-Distance Repression by Human Silencers: Chromatin Interactions and Phase Separation in Silencers. Cells,11(9), 1560. (IF=41.6)
  1. Mirzaei, S., Saghari, S., Bassiri, F., Raesi, R., Zarrabi, A., Hushmandi, K., Sethi, G., & Tergaonkar, V. (2022). NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. Journal of cellular physiology, 237(7), 2770–2795. (IF=6.5)
  1. Morgan, D., Tergaonkar, V. (2022). Unraveling B cell trajectories at single cell resolution. Trends in immunology, 43(3), 210–229. (IF=16.6)
  1. Shanmugam, R., Ozturk, M. B., Low, J. L., Akincilar, S. C., Chua, J., Thangavelu, M. T., Periyasamy, G., DasGupta, R., Tergaonkar, V. (2022). Genome-wide screens identify specific drivers of mutant hTERTProceedings of the National Academy of Sciences of the United States of America, 119(3), e2105171119. (IF=11.2)
  1. Teoh, P. J., An, O., Chung, T. H., Vaiyapuri, T., Raju, A., Hoppe, M. M., Toh, S., Wang, W., Chan, M. C., Fullwood, M. J., Jeyasekharan, A. D., Tergaonkar, V., Chen, L., Yang, H., Chng, W. J. (2022). p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain). Oncogene, 41(14), 2106–2121. (IF=9.8)
  1. Lee, S. Y., Teng, Y., Son, M., Ku, B., Moon, H. S., Tergaonkar, V., Chow, P. K., Lee, D. W., & Nam, D. H. (2021). High-dose drug heat map analysis for drug safety and efficacy in multi-spheroid brain normal cells and GBM patient-derived cells.PloS one, 16(12), e0251998. (IF=3.2)
  1. Lam, H. Y., Tergaonkar, V., Kumar, A. P., & Ahn, K. S. (2021). Mast cells: Therapeutic targets for COVID-19 and beyond. IUBMB life, 73(11), 1278–1292. (IF=3.8)
  1. Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A, Seyed Saleh SH, Bagherian M, Sharifzadeh SO, Hushmandi K, Liskova A, Kubatka P, Makvandi P, Tergaonkar V, Kumar AP, Ashrafizadeh M, Sethi G. (2021). Regulation of nuclear factor-KappaB (NF-KB) Signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis? Cancer Lett. 516:36-37.(IF=8.6)
  1. Cao, F., Zhang, Y., Cai, Y., Animesh, S., Zhang, Y., Akincilar, S. C., Loh, Y. P., Li, X., Chng, W. J., Tergaonkar, V., Kwoh, C. K., & Fullwood, M. J. (2021). Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequences. Genome biology, 22(1), 226. (IF=13.5)
  1. Lee, S. Y., Teng, Y., Son, M., Ku, B., Hwang, H. J., Tergaonkar, V., Chow, P. K., Lee, D. W., & Nam, D. H. (2021). Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate. Molecules (Basel, Switzerland), 26(16), 4949. (IF=4.1)
  1. Daria C, Daniel D’A, Federica B, Laura G, Laura T, James L. Alexander, Alessandra DV, Shi-Chi L, Thamil S. V, James K. E, Daniela V, Jason B, Luca S, Yue M, James S. M, Maria LD, Sam E.M, Kern RC, Hector C.K, Gary Ft, Tergaonkar, V., Katarzyna B, Walter S, Zoltan T, James M. K, Gabriele C, and Guido F. (2021). Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma. The Journal of clinical investigation, 131(11), e137845. (IF=14.8)
  1. Ma, J., Scott, C. A., Ho, Y. N., Mahabaleshwar, H., Marsay, K. S., Zhang, C., Teow, C. K., Ng, S. S., Zhang, W., Tergaonkar, V., Partridge, L. J., Roy, S., Amaya, E., & Carney, T. J. (2021). Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX. eLife, 10, e66596. (IF=8.1)
  1. Cildir, G., Yip, K. H., Pant, H., Tergaonkar, V., Lopez, A. F., Tumes, D. J. (2021). Understanding mast cell heterogeneity at single cell resolution. Trends in immunology, 42(6), 523–535. (IF=16.7)
  1. Lee, C., Kerouanton, B., Chothani, S., Zhang, S., Chen, Y., Mantri, C. K., Hock, D. H., Lim, R., Nadkarni, R., Huynh, T., Lim, D., Chew, W. L., Zhong, F. L., Stroud, D. A., Schafer, S., Tergaonkar, V., St John, A. L., Rackham, O., & Ho, L. (2021). Coding and non-coding roles of MOCCI (C15ORF48) coordinate to regulate host inflammation and immunity. Nature communications, 12(1), 2130. (IF=14.9)
  1. Akincilar, S. C., Chan, C., Ng, Q. F., Fidan, K., Tergaonkar, V. (2021). Non-canonical roles of canonical telomere binding proteins in cancers. Cellular and molecular life sciences : CMLS, 78(9), 4235–4257. (IF=9.2)
  1. Stephenson, E. M., Usselmann, L., Tergaonkar, V., Virshup, D. M., & Dallmann, R. (2021). Cancer clocks in tumourigenesis: the p53 pathway and beyond. Endocrine-related cancer, 28(4), R95–R110. (IF=5.6)
  1. Mansilla MO, Salazar-Hernandez C, Perrin SL, Scheer KG, Cildir G, Toubia J, Sedivakova K, Tea MN, Lenin S, Ponthier E, Yeo ECF, Tergaonkar V, Poonnoose S, Ormsby RJ, Pitson SM, Brown MP, Ebert LM, Gomez GA. (2021). 3D-printed microplate inserts for long term high-resolution imaging of live brain organoids. BMC Biomedical Engineering. 3(1), 6. (IF= NA)
  1. Shin, E. M., Huynh, V. T., Neja, S. A., Liu, C. Y., Raju, A., Tan, K., Tan, N. S., Gunaratne, J., Bi, X., Iyer, L. M., Aravind, L., Tergaonkar, V. (2021). GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer. Science advances, 7(12), eabe2470. (IF=14.1)
  1. Akıncılar, S. C., Wu, L., Ng, Q. F., Chua, J., Unal, B., Noda, T., Chor, W., Ikawa, M., & Tergaonkar, V. (2021). NAIL: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis. Gut, 70(10), 1857–1871. (IF=23.0)
  1. Chen, Y., Ho, L., Tergaonkar, V. (2021). sORF-Encoded MicroPeptides: New players in inflammation, metabolism, and precision medicine. Cancer letters, 500, 263–270. (IF=8.6)
  1. Cai, Y., Zhang, Y., Loh, Y. P., Tng, J. Q., Lim, M. C., Cao, Z., Raju, A., Lieberman Aiden, E., Li, S., Manikandan, L., Tergaonkar, V., Tucker-Kellogg, G., & Fullwood, M. J. (2021). H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. Nature communications,12(1), 719. (IF=14.9)
  1. Shin, E.M., Neja, S.A., Fidan, K. et al.(2020) Lymphocyte cytosolic protein 1 (LCP1) is a novel TRAF3 dysregulation biomarker with potential prognostic value in multiple myeloma. Genome Instability & Disease. 1, 286-299 (IF=NA)
  1. Chen Y, Tergaonkar V. (2020). LncRNAs: Master Regulators in Disease and Cancer. Proceedings of the Singapore National Academy of Science. 14(2), 78-89. (IF=9.4)
  1. Beauchamp, E., Yap, M. C., Iyer, A., Perinpanayagam, M. A., Gamma, J. M., Vincent, K. M., Lakshmanan, M., Raju, A., Tergaonkar, V., Tan, S. Y., Lim, S. T., Dong, W. F., Postovit, L. M., Read, K. D., Gray, D. W., Wyatt, P. G., Mackey, J. R., & Berthiaume, L. G. (2020). Targeting N-myristoylation for therapy of B-cell lymphomas. Nature communications, 11(1), 5348. (IF=14.9)
  1. Morgan, D., Garg, M., Tergaonkar, V., Tan, S. Y., Sethi, G. (2020). Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis. Biochimica et biophysica acta. Reviews on cancer, 1874(2), 188449. (IF=10.6)
  1. Khattar, E., Tergaonkar, V. (2020). Role of Rap1 in DNA damage response: implications in stem cell homeostasis and cancer. Experimental hematology, 90, 12–17. (IF=3.0)
  1. Wong, A. H., Shin, E. M., Tergaonkar, V., Chng, W. J. (2020). Targeting NF-κB Signaling for Multiple Myeloma. Cancers, 12(8), 2203. (IF=6.6)
  1. Tan, E. E., Hopkins, R. A., Lim, C. K., Jamuar, S. S., Ong, C., Thoon, K. C., Koh, M. J., Shin, E. M., Lian, D. W., Weerasooriya, M., Lee, C. Z., Soetedjo, A., Lim, C. S., Au, V. B., Chua, E., Lee, H. Y., Jones, L. A., James, S. S., Kaliaperumal, N., Kwok, J., Tan ES, Thomas B, Ho L, Wu L, Fairhurst AM, Ginhoux F, Teo AK, Zhang Y, Ong KH, Yu W, Venkatesh B, Tergaonkar V, Reversade B, Chin KC, Tan AM, Liew WK, Connolly, J. E. (2020). Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. The Journal of clinical investigation, 130(11), 5817–5832. (IF=14.8)
  1. Lam, H. Y., Arumugam, S., Bae, H. G., Wang, C. C., Jung, S., St John, A. L., Hong, W., Han, W., Tergaonkar, V. (2020). ELKS1 controls mast cell degranulation by regulating the transcription of Stxbp2 and Syntaxin 4 via Kdm2b stabilization.Science advances, 6(31), eabb2497. (IF=14.1)
  1. Ramadass, V., Vaiyapuri, T., Tergaonkar, V. (2020). Small Molecule NF-κB Pathway Inhibitors in Clinic. International journal of molecular sciences, 21(14), 5164. (IF=5.9)
  1. Fernandes, S. G., Dsouza, R., Pandya, G., Kirtonia, A., Tergaonkar, V., Lee, S. Y., Garg, M., & Khattar, E. (2020). Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential. Cancers (Basel), 12(7), 1901. (IF=6.6)
  1. Lam, H. Y., Tergaonkar, V., & Ahn, K. S. (2020). Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies. Bioscience reports, 40(4), BSR20200256. (IF=3.8)
  1. Boyle ST,  Poltavets V,  Kular J, Pyne N, Sandow J,  Lewis A, Murphy KJ, Kolesnikoff N, Moretti P, Tea M, Tergaonkar V, Timpson P, Pitson S,  Webb A, Lopez AF, Kochetkova M, Samuels M. (2020). ROCK-mediated activation of PERK signaling causes fibroblast education and tumor progression by a CRELD2-dependent mechanism. Nature Cell Biology. 22(7):882-895. (IF=28.8)
  1. Pua KH, Chew CL, Lane DP, Tergaonkar V. (2019). Inflammation-associated genomic instability in cancer. Genome Instability & Disease. 1007/s42764-019-00006-6. (IF NA)
  1. Khattar E, Maung KZY, Chew CL, Ghosh A, Mok MMH, Lee P, Zhang J, Chor WHJ, Cildir G, Wang CQ, Mohd-Ismail NK, Chin DWL, Lee SC, Yang H, Shin YJ, Nam DH, Chen L, Kumar AP, Deng LW, Ikawa M, Gunaratne J, Osato M, Tergaonkar V. (2019). Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy. Nature Communication. 10(1):5349. (IF=14.9)
  1. Cildir G, Toubia J, Yip KH, Zhou M, Pant H, Hissaria P, Zhang J, Hong W, Robinson N, Grimbaldeston MA, Lopez AF, Tergaonkar V. (2019). Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases. Immunity. 51(5):949-965. F1000 highlight. (IF=31.7)
  1. Ong MS, Tergaonkar V. (2019). When alpha meets beta, mast cells get hyper. J Exp Med.10.1084. (IF=3.9)
  1. Fischer J, Gutièrrez S, Ganesan R, Calabrese C, Ranjan R, Cildir G, Hos NJ, Rybniker J, Wolke M, Fries JWU, Tergaonkar V, Plum G, Antebi A, Robinson N. (2019). Leptin signaling impairs macrophage defenses against Salmonella Typhimurium. Proc Natl Acad Sci U S A. 1073. (IF=11.2)
  1. Njah K, Chakraborty S, Qiu B, Arumugam S, Raju A, Pobbati AV, Lakshmanan M, Tergaonkar V, Thibault G, Wang X, Hong W. (2019). A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis. Cell Rep. 28(4):949-965. (IF=9.4)
  1. Shin YJ, Sa JK, Lee Y, Kim D, Chang N, Cho HJ, Son M, Oh MYT, Shin K, Lee JK, Park J, Jo YK, Kim M, Paddison PJ, Tergaonkar V, Lee J, Nam DH. (2019). PIP4K2A as a negative regulator of Phosphoinositide 3-Kinase Signaling in PTEN-deficient glioblastoma. J Exp Med. 216(5):1120-1134. (IF=3.9)
  1. Chipurupalli S, Kannan E, Tergaonkar V, D’Andrea R, Robinson N.(2019). Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer. Int J Mol Sci. 20(3). (IF=5.9)
  1. Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, Tergaonkar V, Sethi G. (2019). The expanding roles of long non-coding RNAs in the regulation of cancer stem cells. Int J Biochem Cell Biol. 108:17-20. (IF=3.6)
  1. Tvorogov D, Thomas D, Liau NPD, Dottore M, Barry EF, Lathi M, Kan WL, Hercus TR, Stomski F, Hughes TP, Tergaonkar V, Parker MW, Ross DM, Majeti R, Babon JJ, Lopez AF. (2018). Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis.. 4(11). (IF=14.1)
  1. Chong YC, Lim TE, Fu Y, Shin EM, Tergaonkar V, Han W. (2018). Indian Hedgehog links obesity to development of hepatocellular carcinoma. Oncogene. 10.1038.(IF=9.8)
  1. Kumar R, Coronel L, Somalanka B, Raju A, Aning OA, An O, Ho YS, Mak SY, Hor PY, Yang H, Lakshmanan M, ltoh H, Tan SY, Lim YK, Wong APC, Chew SH, Huynh TH, Goh BC, Lim CY, Tergaonkar V, Cheok CF. (2018). Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nature Communication. 9:3931. (IF=14.9)
  1. Xu X, Li Y, Bharath SR,Ozturk MB, Bowler MW, Loo BZL,Tergaonkar V*, Song H. (2018). Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1. Nature Communication. 9(1):3183. *Corresponding Author (IF=14.9)
  1. Puar YR, Shanmugam MK, Fan L, Arfuso F, Sethi G, Tergaonkar V. (2018). Evidence for the involvement of the Master Transcription Factor NF-kB in Cancer Initiation and Progression. Biomedicines. 6(3). (IF=6.0)
  1. Maung KZY, Leo PJ, Bassal M, Casolari DA, Gray JX, Bray SC, Pederson S, Singhal D, Samaraweera SE, Nguyen T, Cildir G, Marshall M, Ewing A, Duncan EL, Brown MA, Saal R, Tergaonkar V, To LB, Marlton P, Gill D, Lewis I, Deans AJ, Brown AL, D’Andrea RJ, Gonda TJ. (2018). Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia. Blood Cancer J. 8(6):5. (IF=11.0)
  1. Ding Y, Liang X, Zhang Y, Yi L, Shum HC, Chen Q, Chan BP, Fan H, Liu Z, Tergaonkar V, Qi Z, Tse HF, Lian Q. (2018). Rap1 deficiency-provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation. Cell Death Dis. 9(3):386. (IF=8.4)
  1. Gomez GA, M Woodcock J, Tergaonkar V, A Gregory P. (2018). Meeting report: The 8th Barossa Meeting-Cell Signaling in Cancer Medicine in the Barossa Valley, Australia. Cell Death Dis. 9(3):284. (IF=8.4)
  1. Tan CSH, Go KD, Bisteau X, Dai L, Han Y, Prabhu N, Ozturk MB, Lim YT, Lengqvist J, Tergaonkar V, Sobota, Nordlund P. (2018). Thermal proximity coaggregation for system-wide monitoring of protein complex dynamics in intact cell. Science. 9(3):284. (IF=41.8)
  1. Yan T, Ooi WF, Qamra A, Cheung A, Ma D, Sundaram GM, Xu C, Xing M, Poon L, Wang J, Loh YP, Ho JHJ, Ng JJQ, Ramlee MK, Aswad L, Rozen SG, Ghosh S, Bard FA, Sampath P, Tergaonkar V, Davies JOJ, Hughes JR, Goh E, Bi X, Fullwood MJ, Tan P, Li S. (2018). HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis. Nature Communication. 9(1):100. (IF=14.9)
  1. Rasheed SAK, Leong HS, Lakshmanan M, Raju A, Dadlani D, Chong FT, Shannon NB, Rajarethinam R, Skanthakumar T, Tan EY, Hwang JSG, Lim KH, Tan DS, Ceppi P, Wang M, Tergaonkar V, Casey PJ, Iyer NG. (2018). GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers. Oncogene. 37(10):1340-1353. (IF=9.8)
  1. Chew CL, Conos SA, Unal B, Tergaonkar V. (2018). Noncoding RNAs: Master Regulators of Inflammatory Signaling. Trends Mol Med. 24(1):66-84. (IF=11.9)
  1. Cildir G, Pant H, Lopez AF, Tergaonkar V. (2017). The transcriptional program, functional heterogeneity, and clinical targeting of mast cells. J Exp Med. 214(9):2491-2506. (IF=3.9)
  1. Shen H, Shin EM, Lee S, Mathavan S, Koh H, Osato M, Choi H, Tergaonkar V, Korzh V. (2017). Ikk2 regulates cytokinesis during vertebrate development. Sci Rep. 7(1):8094. (IF=4.3)
  1. Mzoughi S, Zhang J, Hequet D, Teo SX, Fang H, Xing QR, Bezzi M, Seah MKY, Ong SLM, Shin EM, Wollmann H, Wong ESM, Al-Haddawi M, Stewart CL, Tergaonkar V, Loh YH, Dunn NR, Messerschmidt DM, Guccione E. (2017). PRDM15 safeguards naive pluripotency by transcriptionally regulating WNT and MAPK-ERK signaling. Nature Genet. 49(9):1354-1363.(IF=38.3)
  1. Hercus TR, Kan WLT, Broughton SE, Tvorogov D, Ramshaw HS, Sandow JJ, Nero TL, Dhagat U, Thompson EJ, Shing KSCT, McKenzie DR, Wilson NJ, Owczarek CM, Vairo G, Nash AD, Tergaonkar V, Hughes T, Ekert PG, Samuel MS, Bonder CS, Grimbaldeston MA, Parker MW, Lopez AF. (2017). Role of the β Common (βc) Family of Cytokines in Health and Disease. Cold Spring Harb Perspect Biol. pii: a028514. (IF=10.0)
  1. Conn VM, Hugouvieux V, Nayak A, Conos SA, Capovilla G, Cildir G, Jourdain A, Tergaonkar V, Schmid M, Zubieta C, Conn SJ. (2017). A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation. Nature Plants. 3:17053. (IF=15.7)
  1. Zhang Y, Chiu S, Liang X, Chai YH, Qin Y, Wang J, Li X, Qiu B, Tergaonkar V, Tse HF, Lian Q. (2017). Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection. Exp Cell Res. 356(1):74-84. (IF=3.9)
  1. Wang CQ, Mok MM, Yokomizo T, Tergaonkar V, Osato M. (2017). Runx Family Genes in Tissue Stem Cell Dynamics. Adv Exp Med Biol. 962:117-138. (IF=2.6)
  1. Chakraborty S, Njah K, Pobbati AV, Lim YB, Raju A, Lakshmanan M, Tergaonkar V, Lim CT, Hong W. (2017). Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway. Cell Reports. 18(10):2464-2479. (IF=9.4)
  1. Ozturk MB, Li Y, Tergaonkar V. (2017). Current Insights to Regulation and Role of Telomerase in Human Diseases. Antioxidants (Basel). 6(1). (IF=6.3)
  1. Khattar E, Tergaonkar V. (2017). Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC. Front Cell Dev Biol. 5:1. (IF=6.6)
  1. Cai W, Chen ZX, Rane G, Singh SS, Choo Z, Wang C, Yuan Y, Tan TZ, Arfuso F, Yap CT, Pongor LS, Yang H, Lee MB, Goh BC, Sethi G, Benoukraf T, Tergaonkar V, Kumar AP. (2017). Wanted DEAD/H or Alive: Helicases Winding Up in Cancers. J Natl Cancer Inst. 109(6). (IF=13.5)
  1. Poon MW, Jiang D, Qin P, Zhang Y, Qiu B, Chanda S, Tergaonkar V, Li Q, Wong IY, Yu Z, Tse HF, Wong DS, Lian Q. (2017). Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali Burn. Sci Rep. 7:41224. (IF=4.3)
  1. Liau WS, Tan SH, Ngoc PCT, Wang CQ, Tergaonkar V, Feng H, Gong Z, Osato M, Look AT, Sanda T. (2017). Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Leukemia. 31(8): 1798-1807. (IF=11.5)
  1. Li Y, Cheng, HS, Chng WJ, Tergaonkar V. (2016). Activation of mutant TERT promoter by RAS-ERK signalling is a key step in the malignant progression of BRAF-mutant human melanomas. Proc Natl Acad Sci U S A. 113(50):14402-14407. (IF=11.2)
  1. Akıncılar SC, Khattar E, Boon PL, Unal B, Fullwood MJ, Tergaonkar V. (2016). Long-range chromatin interactions drive mutant Tert promoter activation. Cancer Discovery. 6(11):1276-1291. (IF=39.3)
  1. Jayapal SR, Ang HY, Wang CQ, Bisteau X, Caldez MJ, Xuan GX, Yu W, Tergaonkar V, Osato M, Lim B, Kaldis P. (2016). Cyclin A2 regulates erythrocyte morphology and numbers. Cell Cycle. 15(22):3070-3081. (IF=4.5)
  1. Khattar E, Kumar P, Liu CY, Akıncılar SC, Raju A, Lakshmanan M, Maury JJ, Qiang Y, Li S, Tan EY, Hui KM, Shi M, Loh YH, Tergaonkar V. (2016). Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. Journal of Clinical Investigation. 126(10):4045-4060. Covered by local and international press. (IF=14.8)
  1. Shin EM, Osato M, Kumar AP, Tergaonkar V. (2016). RNA helicase DP103 and Tak1: a new connection in cancer. Mol Cell Oncol. 2(3): e985911. (IF=1.1)
  1. Mahara S, Lee PL, Feng M, Tergaonkar V, Chng WJ, Yu Q. (2016). HIF1a activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer. Proc Natl Acad Sci U S A. 113(26): E3735-44. (IF=11.2)
  1. Liu CC, Ma DL, Yan TD, Fan X, Poon Z, Poon LF, Goh SA, Rozen SG, Hwang WY, Tergaonkar V, Tan P, Ghosh S, Virshup DM, Goh EL, Li S. (2016). Distinct responses of stem cells to telomere uncapping-A potential strategy to improve the safety of cell therapy. Stem Cells. 34(10):2471-2484. (IF=6.2)
  1. Toh CX, Chan JW, Chong ZS, Wang HF, Guo HC, Satapathy S, Ma D, Goh GY, Khattar E, Yang L, Tergaonkar V, Chang YT, Collins JJ, Daley GQ, Wee KB, Farran CA, Li H, Lim YP, Bard FA, Loh YH. (2016). RNAi reveals phase-specific global regulators of human somatic cell reprogramming. Cell Rep. 15(12):2597-607. (IF=9.4)
  1. Asfa AS, Qiu B, Wee S, Choi H, Gunaratne J, Tergaonkar V. (2016). Phosphoprotein network analysis of white adipose tissue unveils deregulated pathways in response to high-fat diet. Sci Rep. 6:25844. (IF=4.3)
  1. Cildir G, Low KC, Tergaonkar V. (2016). Non canonical NFkB signaling in health and disease. Trends Mol Med. 22(5):414-29. (IF=11.9)
  1. Li CX, Lo CM, Lian Q, Ng KT, Liu XB, Ma YY, Qi X, Yeung OW, Tergaonkar V, Yang XX, Liu H, Liu J, Shao Y, Man K. (2016). Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response. Oncotarget. 7 (19):27711-23. (IF=4.1)
  1. Shanmugam MK, Lee JH, Chai EZ, Kanchi MM, Kar S, Arfuso F, Dharmarajan A, Kumar AP, Ramar PS, Looi CY, Mustafa MR, Tergaonkar V, Bishayee A, Ahn KS, Sethi G. (2016). Cancer prevention and therapy by modulation of transcription by bioactive natural compounds. Semin Cancer Biol. 40-41:35-47. (IF=15.7)
  1. Li Y, Tergaonkar V. (2016). Telomerase reactivation in cancer: mechanisms that govern activation of Wild-type versus mutant promoter. Transcription. 7(2):44-9.(IF=3.0)
  1. Akincilar SC, Unal B, Tergaonkar V. (2016). Reactivation of Telomerase in Cancer. Cell Mol Life Sci. 73(8):1659-70. (IF=9.2)
  1. Dewaele M, Tabaglio T, Willekens K, Bezzi M, Teo SX, Low DH, Koh CM, Rambow F, Fiers M, Rogiers A, Radaelli E, Al-Haddawi M, Tan SY, Hermans E, Amant F, Yan H, Lakshmanan M, Koumar RC, Lim ST, Derheimer FA, Campbell RM, Bonday Z, Tergaonkar V, Shackleton M, Blattner C, Marine JC, Guccione E. (2016). Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. Journal of Clinical Investigation. 126(1):68-84. (IF=14.8)
  1. Tergaonkar V. (2015). NFkB drives mutant TERT promoter activation. Cell Cycle. 14(22):3580-92. (IF=4.5)
  1. Cai Y, Sukhova GK, Wong HK, Xu A, Tergaonkar V, Vanhoutte PM, Tang EH. (2015). Rap1 induces cytokine production in pro-inflammatory macrophages through NFkB signaling and is highly expressed in human atherosclerotic lesions. Cell Cycle. 14(22):3580-92. (IF=4.5)
  1. Zhang Y, Zhang Z, Gao F, Tse HF, Tergaonkar V, Lian Q. (2015). Paracrine regulation in mesenchymal stem cells: the role of Rap1. Cell Death Dis. 6: e1932. (IF=6.2)
  1. Li Y, Zhou QL, Sun W, Chandrasekharan P, Cheng HS, Ying Z, Lakshmanan M, Raju A, Tenen DG, Cheng SY, Chuang KH, Li J, Prabhakar S, Li M, Tergaonkar V. (2015). Non-canonical NFkB signaling and ETS1/2 cooperatively drive mutant TERT promoter activation. Nature Cell Biology. 17(10):1327-38. (IF=28.8)
  1. Yang BX, El Farran CA, Guo HC, Yu T, Fang HT, Wang HF, Schlesinger S, Seah YF, Goh GY, Neo SP, Li Y, Lorincz MC, Tergaonkar V, Lim TM, Chen L, Gunaratne J, Collins JJ, Goff SP, Daley GQ, Li H, Bard FA, Loh YH. (2015). Systemic identification of factors for provirus silencing in embryonic stem cells. Cell. 163(1):230-45. (IF=41.5)
  1. Qiu B, Shi X, Zhou Q, Chen HS, Lim J, Han W, Tergaonkar V. (2015). Hypothalamic NUCKS regulates peripheral glucose homeostasis. Biochemical J. 469(3):391-8. (IF=3.8)
  1. Chin DW, Watanabe-Okochi N, Wang CQ, Tergaonkar V, Osato M. (2015). Mouse models for core binding factor. Leukemia. 29(10):1970-80. (IF=11.5)
  1. Tergaonkar V. (2015). Catalytically Inactive Telomerase in oncogenesis. Oncotarget. 6(17):14725-6. (IF=4.1)
  1. Koh CM, Khattar E, Leow SC, Liu CY, Muller J, Ang WX, Li Y, Franzoso G, Li S, Guccione E, Tergaonkar V. (2015). Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. Journal of Clinical Investigation. 125(5):2019-22. (IF=14.8)
  1. Qiu B, Han W, Tergaonkar V. (2015). NUCKS a potential biomarker in cancer and metabolic disease. Clinical Science. 128(10): 715-21. (IF=6.1)
  1. Akıncılar SC, Low KC, Liu CY, Yan TD, Oji A, Ikawa M, Li S, Tergaonkar V. (2015). Quantitative assessment of telomerase components in cancer cell lines. FEBS Lett. 589(9): 974-84. (IF=4.1)
  1. Chakraborty S, Lakshmanan M, Swa HL, Chen J, Zhang X, Ong YS, Loo LS, Akıncılar SC, Gunaratne J, Tergaonkar V, Hui KM, Hong W. (2015). An oncogenic role for Agrin in mediating focal adhesion integrity in hepatocellular carcinoma. Nature Communication. 6:6184. (IF=14.9)
  1. Jayapal SR, Wang CQ, Bisteau X, Caldez MJ, Lim S, Tergaonkar V, Osato M, Kaldis P. (2015). Haematopoiesis specific loss of cdk2 and cdk4 results in increased erythrocyte size and delayed platelet recovery following stress. Haematologica. 100(4): 431-8.(IF=9.9)
  1. Koh CP, Ng CE, Nah GS, Wang CQ, Tergaonkar V, Matsumura T, Yokomizo, Suda T, Osato M. (2015). Haematopoietic stem cell enhancer: a powerful tool in stem cell biology. Histol & Histopathol. 30(6):661-72. (IF=2.3)
  1. Poon MW, Yan L, Jiang D, Qin P, Tse HF, Wong IY, Wong DS, Tergaonkar V*, Lian Q. (2015). Inhibition of Rap1 enhances corneal recovery following alkali injury. Invest Ophthalmol Vis Sci. 56(2): 711-21. *Corresponding Author (IF=4.7)
  1. Zhang Y, Chiu S, Liang X, Gao F, Zhang Z, Liao S, Liang Y, Chai YH, Low DJ, Tse HF, Tergaonkar V, Lian Q. (2015). Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction. Cell Death Discovery. 1:15007. (IF=5.2)
  1. Wang CQ, Chin DW, Chooi JY, Chng WJ, Taniuchi I, Tergaonkar V, Osato M. (2015). Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis. Leukemia. 29(3):753-7. *Corresponding Author (IF=11.5)
  1. Yan B, Kuick CH, Lim M, Venkataraman K, Tennakoon C, Loh E, Lian D, Leong MY, Lakshmanan M, Tergaonkar V, Sung WK, Soh SY, Chang KT. (2014). Platform comparison for evaluation of ALK protein expression, genomic copy number and hotspot mutation status in neuroblastomas. Plos One. 9(9): e106575. (IF=3.2)
  1. Huang YH, Al-aidaroos AQ, Yuen HF, Zhang SD, Shen HM, Rozycka E, M McCrudden, CM, Tergaonkar V, Gupta A, Lin YB, Thiery JP, Murray JT, Zeng Q. (2014). A role of autophagy in PTP4A3-driven cancer progression. Autophagy. 10(10):1787-800. (IF=16.0)
  1. Siveen KS, Nguyen AH, Lee JH, Li F, Singh SS, Kumar AP, Low G, Jha S, Tergaonkar V, Ahn KS, Sethi G. (2014). Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells. British Journal of Cancer. 111(7): 1327-37. (IF=7.6)
  1. Shin EM, Hay HS, Lee MH, GohJN, Tan TZ, Sen YP, Lim SW, Yousef EM, Ong HT, Thike AA, Kong X, Wu Z, Mendoz E, Sun W, Salto-Tellez M, Lim CT, Lobie PE, Lim YP, Yap CT, Zeng Q, Sethi G, Lee MB, Tan P, Goh BC, Miller LD, Thiery JP, Zhu T, Gaboury L, Tan PH, Hui KM, Yip GW, Miyamoto S, Kumar AP, Tergaonkar V. (2014). DEAD-box helicase DP103 defines the metastatic potential of human breast cancers.                                            Journal of Clinical Investigation. 24(9):3807-24. Covered by local and international press. (IF=14.8)
  1. Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY, Nah GS, Du L, Jacob B, Yamashita N, Lai SK, Tan TZ, Mori S, Tanuichi I, Tergaonkar V, Ito Y, Osato M. (2014). Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects. Cell Reports. 8(3):767-82. *Corresponding Author/ Covered by local press (IF=9.4)
  1. Beiying Qiu, Xiaohe Shi, EeTsin Wong, Joy Lim, Hannah L.F. Swa, Jayantha Gunaratne, Kenneth Cheng, Karen Lam, Aimin Xu, Weiping Han, Tergaonkar V. (2014). NUCKS is a positive transcriptional regulator of insulin signaling. Cell Reports. 7(6):1876-86. Covered by local and international press. (IF=9.4)
  1. Tong L, Tergaonkar V. (2014). Rho protein GTPases and their interactions with NFkB: crossroads of inflammation and matrix biology. Biosci Rep. 34(3). (IF=3.8)
  1. Mok MM, Du L, Wang CQ, Tergaonkar V, Liu TC, Yin Kham SK, Sanda T, Y, Osato M. (2014). RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells. Gene. 545(1):111-6. (IF=3.6)
  1. Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, Kumar AP, Fong CW, Tergaonkar V, Hui KM, Sethi G. (2014). Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in orthotopic mouse model. Oncotarget. 5(7):1897-911. (IF=4.1)
  1. Li Y, Tergaonkar V. (2014). Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies. Cancer Res. 74(6):1639-44. (IF=12.7)
  1. Low KC, Tergaonkar V. (2013). Telomerase: a central regulator of all hallmarks of cancer. Trends in Biochemical Sciences. 38(9):426-34. (IF=13.8)
  1. Koh CP, Wang CQ, Ng CE, Ito Y, Araki M, Tergaonkar V, Huang G, Osato, M. (2013). RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes. Leukemia. 27(9):1793-802. (IF=11.5)
  1. Cildir G, Akincilar SC, Tergaonkar V. (2013). Chronic adipose tissue inflammation: all immune cells on the stage. Trends in Molecular Medicine. 19(8): 487-500. (IF=11.9)
  1. Wang CQ, Motoda L, Satake M, It Y, Taniuchi I, Tergaonkar V, Osato M. (2013). Runx3 deficiency results in myeloproliferative disorder in aged mice. Blood. 122(4):562-6. (IF=22.1)
  1. Shi X, Wang X, Li Q, Su M, Chew E, Wong ET, Radda GK, Tergaonkar V*, Han W. (2013). NFkB suppresses food intake and energy expenditure in mice by activating the POMC promoter. Diabetologia. 56(4):925-36. * Corresponding Author (IF=10.1)
  1. Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, Zhou J, Chng WJ, Li S, Liu E, Tergaonkar V. (2012). Telomerase directly regulates NFkB dependent transcription. Nature Cell Biology. 14(12):1270-81. Covered by local and international press. F1000 highlight. (IF=28.8)
  1. Rajendran P, Li F, Shanmugam MK, Kannaiyan R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, Luk JM, Sethi G. (2012). Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res. 5(4):631-43. (IF=3.4)
  1. Sethi G, Shanmugam M, Kumar AP, Tergaonkar V. (2011). Multifaceted link between cancer and inflammation. Bioscience Reports. 32(1):1-15. (IF=3.8)
  1. Mauro C, Leow SC, Anso E, Rocha S, Thotakura A, Tornatore L, Moretti M, De Smaele E, Beg A, Tergaonkar V, Franzoso G. (2011). NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nature Cell Biology. 13(10):1272-9. Covered by local and international press. (IF=28.8)
  1. Wang T, Zhang M, Ma Z, Tergaonkar V, Zeng Q, Hong W. (2012). A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal. J Cell Physiol. 227(6):2788-97.(IF=6.3)
  1. Wu Z, Wong ET, Shi Y, Chen Z, Miyamoto S, Tergaonkar V. (2010). ATM and NEMO-dependent ELKS ubiquitination coordinates TAk1-mediated IKK activation in response to genotoxic stress. Molecular Cell. 40(1): 75-86. (IF=17.9)
  1. Ghosh A and Tergaonkar V. (2010). Telomeres and inflammation: Rap1 joins the ends? Cell Cycle. 9(19):3834-5. (IF=4.5)
  1. Teo H, Ghosh S, Luesch H, Wong ET, Ghosh A, Malik N, Orth A, de Jesus P, Perry AP, Oliver JD, Tran NL, Speiser LJ, Saez E, Schultz P, Chanda S, Verma IM, Tergaonkar V. (2010). Telomere independent Rap1 is an IKK-adaptor and regulates NFKB-dependent gene expression. Nature Cell Biology (article). (12)(8):758-67. Covered by local and international press. (IF=28.8)
  1. Susila A, Chan H, Loh AX, Phang HQ, Wong ET, Tergaonkar V, Koh CG. (2010). The POPX2 phosphatase regulates cancer cell motility and invasiveness. Cell Cycle. 9(1): 179-87. (IF=4.5)
  1. Tergaonkar V. (2009). p53 and NF-kappaB: fresh breath in the cross talk. Cell Research. 19(12):1313-5. (IF=25.6)
  1. Sethi G, Tergaonkar V. (2009). Potential pharmacological control of the NF-kappaB pathway. Trends in Pharmacological Sciences. 30(6): 313-21. (IF=14.8)
  1. Chew J, Biswas S, Shreeram S, Humaidi M, Wong ET, Dhillion MK, Teo H, Hazra A, Fang CC, López-Collazo E, Bulavin DV, Tergaonkar V. (2009). WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nature Cell Biology. 11(5):659-66. Covered by local and international press. (IF=28.8)
  1. Shen HM, Tergaonkar V. (2009). NF-kappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 14(4), 348-63. (IF=4.6)
  1. Wong ET, Tergaonkar V. (2009). Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clinical Science. 116(6), 451-65. (IF=6.1)
  1. Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar V*, Verma IM. (2009). Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.

Proc Natl Acad Sci U S A. 106(8), 2629-34. * Corresponding Author (IF=11.2)

  1. Singh K, Sinha S, Malonia SK, Bist P, Tergaonkar V, Chattopadhyay S. (2009). Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions. J Biol Chem. 284(2), 1267-78. (IF=3.9)
  1. Dey A, Tergaonkar V*, Lane DP. (2008). Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways. Nature Reviews Drug Discovery. 7(12), 1031-40. * Corresponding Author (IF=84.6)
  1. Dey A, Wong E, Kua N, Teo HL, Tergaonkar V*, Lane D. (2008). Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy. Cell Cycle. 7(23), 3759-67. *Corresponding Author (IF=4.5)
  1. Lee KG, Xu S, Wong ET, Tergaonkar V, Lam KP. (2008). Bruton’s tyrosine kinase separately regulates NF-kappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. J Biol Chem. 283(17), 11189-98. (IF=3.9)
  1. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL, Silke J. (2007). IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 131(4), 682-93. (IF=41.5)
  1. Dey A, Wong ET, Cheok CF, Tergaonkar V*, Lane DP. (2008). R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy. Cell Death & Differ. 15(2), 263-73. *Corresponding Author (IF=15.8)
  1. Irelan JT, Murphy TJ, DeJesus PD, Teo H, Xu D, Gomez-Ferreria MA, Zhou Y, Miraglia LJ, Rines DR, Verma IM, Sharp DJ, Tergaonkar V, Chanda SK. (2007). A role for IkappaB kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci U S A. 104(43), 16940-5. (IF=11.2)
  1. Ang HL, Tergaonkar V. (2007). Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function? Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function? Bioessays. 29(10), 1039-47. (IF=4.3)
  1. Dey A, Wong ET, Bist P, Tergaonkar V, Lane DP. (2007). Nutlin-3 inhibits the NF-kappaB pathway in a p53-dependent manner: implications in lung cancer therapy. Cell Cycle. 6(17), 2178-85. (IF=4.5)
  1. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V. (2007). Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. Journal of Immunology. 179(6), 4083-92. (IF=5.4)
  1. Biswas SK, Tergaonkar V. (2007). Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance? Int J Biochem Cell Biol. 39(9), 1582-92. (IF=3.6)
  1. Tergaonkar V*, Perkins ND. (2007). p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Molecular Cell. 26(2), 158-9. *Corresponding author (IF=17.9)
  1. Basak S, Kim H, Kearns JD, Tergaonkar V, O’Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, Hoffmann A. (2007). A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 128(2), 369-81. (IF=41.5)
  1. Ghosh S, Tergaonkar V*, Rothlin CV, Correa RG, Bottero V, Bist P, Verma IM, Hunter T. (2006). Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell. 10(3), 215-26. *Co-first author (IF=31.7)
  1. Tergaonkar V. (2006). NFkappaB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol. 38(10), 1647-53. (IF=3.6)

 

Publications before joining IMCB

  1. Muotri AR, Bottero V, Tergaonkar V, Correa RG. (2006). UV-mediated NF-kappaB activation is abolished in deficient XPC/D primary fibroblasts Cell Cycle. 5(10), 1085-9. (IF=4.5)
  1. Tergaonkar V, Correa RG, Ikawan M. and Verma IM. (2005). Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nature Cell Biology. 7(9): 921-3. (IF=28.8)
  1. Correa RG, Matsui T*, Tergaonkar V*, Rodriguez-Esteban C, Izpisua-Belmonte JC, Verma IM. (2005). Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Current Biology. 15(14): 1291-5. *Equal contribution (IF=10.8)
  1. Correa RG, Tergaonkar V, Ng JK, Dubova I, Izpisua Belmonte JC, Verma IM. (2004). Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development. Mol Cell Biol. 24(12): 5257- (IF=6.2)
  1. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S. (2004). Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. Journal of Virology.78(11):5934-45. (IF=5.1)
  1. Tiscornia G, Tergaonkar V, Galimi F, Verma IM. (2004). CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci USA. 101(19): 7347-51. (IF=11.2)
  1. Tergaonkar V, Bottero V, Ikawa M, Li Q, Verma IM. (2003). IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy. Mol Cell Biol. 23(22): 8070-83. Selected as one of the six best papers of the month by American Society for Microbiology (ASM). (IF=6.2)
  1. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. (2002). p53 stabilization is decreased upon NFkB activation: a role for NFkB in acquisition of resistance to chemotherapy. Cancer Cell. 1(5), 493-503. (IF=31.7)
  1. Ikawa M, Tergaonkar V, Ogura A, Ogonuki N, Inoue K, Verma IM. (2002). Restoration of spermatogenesis by lentiviral gene transfer: Offspring from infertile mice. Proc Natl Acad Sci USA. 99(11): 7524-9. Cited by CNN, ABC, Reuters and other news agencies around the world on 28th May 2002. (IF=11.2)
  1. Liu Y, Tergaonkar V, Krishna S, Androphy EJ. (1999). Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor alpha correlates with increased accumulation of reactive oxygen species. J Biol Chem. 274(35), 24819-27. (IF=3.9)
  1. Mythily DV, Krishna S, Tergaonkar V. (1999). Pleiotropic effects of human papillomavirus type 16 E6 oncogene expression in human epithelial cell lines. J Gen Virol. 80(Pt 7):1701-13. (IF=3.8)
  1. Tergaonkar V, Mythily DV, Krishna S. (1997). Cytokeratin patterns of expression in human epithelial cell lines correlate with transcriptional activity of the HPV16 URR.

         J Gen Virol. 78 (Pt 10): 2601-6. (IF=3.8)

Book Chapters and Proceedings

  1. Ekta Khattar and Tergaonkar V. (2016). Telomere – A Complex End of a Chromosome”. Edited by Marcelo L. Larramendy. ISBN 978-953-51-2753-6.
  2. Arka Ghosh and Tergaonkar V. (2012). Extra-Telomeric Roles of Telomeric Proteins in the book “Reviews on Selected Topics of Telomere Biology”. Edited by Bibo Li. InTech. ISBN 978-953-51-0849-8.
  3. Muthu K Shamugam, Tergaonkar V and Gautam Sethi. Inflammation in Cancer Development. (2010). Taylor and Francis Group, LLC, entitled “Inflammation, Life Style and Chronic Diseases: The Silent Link.
  4. Withoff S, Tergaonkar V and Verma IM. (2006). Regulating the master regulator NFkB: From Natural strategies to rationally designed superdrugs. Transcription Factor NFk Book commemorating 20 years of NF-kB. Preface David Baltimore. Cold Spring Harbor Press.
  5. Tergaonkar V, Li Q, and Verma, I.M. (2005) Inhibitors of NFkB activity: Tools for treatment of human ailments. NFkB/Rel Transcription Factor Family.
    Landes Bioscience and Springer. ISBN: 1-58706-270-4.
  6. Krishna S, Sayal R, Mythily D.V, Tergaonkar V and Rangarajan, A. (1999). The role of the Notch pathway in viral induced tumors. Proceedings of the 2nd ICGEB-UCI Virology Symposium Eds S. Jameel ,E.K. Wagner, OUP and IBH. pp1023-1030.
  7. Krishna S, Shashidhara L.S, Deshpande N, Daniel B. and Tergaonkar V. (1996). In vivo approaches to studying human papillomaviruses. Proceedings of the first International Center for Genetic Engineering and Biotechnology (ICGEB)-University of California Irvine (UCI) Virology Symposium. Eds S. Jameel and E.K. Wagner, OUP and IBH. pp 223-230.
  8. Tergaonkar V, Vallikad E. and Krishna S. (1994). Analysis of HPV16 E2 gene expression in the progression of cervical cancers. Proceedings of the XVI International Cancer Congress, Monduzzi Editore 3, 2271-2275.